Product Launch (Blog)

Jun, 21 2023

Active Pharmaceutical Ingredient (API): A Critical Review of Current Biotechnological Approaches

Active pharmaceutical ingredients (APIs) are chemical compounds primarily manufactured in several countries. These APIs possess pharmacological activity and are typically combined with other ingredients to diagnose, cure, mitigate, and treat diseases. In recent years, pharmaceutical companies have increasingly imported APIs from countries where they are produced to their home countries. Modern medicines play a crucial role in preventing, treating, diagnosing, and curing diseases. Each medication comprises two main components: the API, which is the active and biologically active ingredient responsible for its therapeutic effects, and excipients such as lactose or mineral oil, which are chemically inactive and provide volume, flavor, or color to the medication.

According to Data Bridge Market Research the Active Pharmaceutical Ingredient (API) Market accounted for USD 223.3 million in 2022, and expected to reach USD 369.56 million by 2030. The market is expected to grow with a CAGR of 5.8% in the forecast period of 2023 to 2030.

  “Increasing demand of highly potent active pharmaceutical ingredients”

The utilization of highly potent active pharmaceutical ingredients (HPAPIs) represents a significant change in the pharmaceutical industry's approach, as it allows for the development of new medicines using small molecules. The increasing demand for HPAPIs is driven by their advantages, such as lower therapeutic doses, targeted receptor binding, and enhanced efficacy. As the generic API sector becomes more competitive, many API manufacturers are adopting HPAPIs to differentiate themselves, leading to market growth.

What restraints the growth of the active pharmaceutical ingredient (API) market?

“Unavailability of appropriate treatments”

The unavailability of appropriate treatments for active pharmaceutical ingredients (APIs) is a significant concern in the pharmaceutical industry. This issue arises when there is a lack of efficient and effective methods for the synthesis, purification, and formulation of APIs. Without access to suitable treatment options, the quality, safety, and efficacy of pharmaceutical products can be compromised. It is crucial to address this challenge through research, development, and investment in infrastructure and technology to ensure the availability of reliable and high-quality treatments for APIs.

Segmentation: Global Active Pharmaceutical Ingredient (API) Market

The active pharmaceutical Ingredient (API) market is segmented on the basis of molecule, type, type of manufacturer, synthesis, chemical synthesis, type of drug, usage, potency, and therapeutic application.

  • On the basis of molecule, the active pharmaceutical ingredient (api) market is segmented into small molecule, large molecule.
  • On the basis of type, the active pharmaceutical ingredient (api) market is segmented into innovative active pharmaceutical ingredients, generic active pharmaceutical ingredients.
  • On the basis of type of manufacturer, the active pharmaceutical ingredient (api) market is segmented into captive api manufacturer, merchant api manufacturer.
  • On the basis of synthesis, the active pharmaceutical ingredient (api) market is segmented into synthetic active pharmaceutical ingredients, biotech active pharmaceutical ingredients.
  • On the basis of indications, the active pharmaceutical ingredient (api)market is segmented into acetaminophen, artemisinin, saxagliptin, sodium chloride, ibuprofen losartan potassium, enoxaparin sodium, rufinamide, naproxen, tamoxifen, others.
  • On the basis of type of drug, the active pharmaceutical ingredient (api) market is segmented into prescription drugs, over the counter drugs.
  • On the basis of usage, the active pharmaceutical ingredient (api) market is segmented into clinical, research.
  • On the basis of potency, the active pharmaceutical ingredient (api) market is segmented into low-to-moderate potency active pharmaceutical ingredients, potent-to-highly potent active pharmaceutical ingredient.
  • On the basis of therapeutic application, the active pharmaceutical ingredient (api) market is segmented into cardiology, cns and neurology, oncology, orthopaedic, endocrinology, pulmonology, gastroenterology, nephrology, ophthalmology, other therapeutic application.
  • On the basis of distribution channel, the active pharmaceutical ingredient (api) market is segmented into hospital pharmacy, retail pharmacy, online pharmacies, others.

Regional Insights: North America dominates the Active Pharmaceutical Ingredient (API) Market

North America dominates the market owing to the driving growth of active pharmaceutical Ingredient (API) industries across the country. Sandals/flip-flops are the most commonly active pharmaceutical Ingredient (API) in the Asia-Pacific market. The increasing healthcare expenditures and well-established healthcare infrastructure are contributing for the market’s growth.

Asia Pacific is expected to grow during the forecast period of 2023 to 2030 due to the growing awareness of the latest fashion trends among the young generation, growing spending on active pharmaceutical Ingredient (API) from online platforms and mounting inclination to pay a premium for high-quality shoes, the increased consumption demand for active pharmaceutical ingredients is driving the market’s growth in the region.

To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-active-pharmaceutical-ingredient-api-market

Recent Developments in Active Pharmaceutical Ingredient (API) Market

  • In 2021, U.S. FDA approved a new drug by Teva Pharmaceutical and MEDinCell to treat schizophrenia. Furthermore, legal issues are decelerating down the establishment of new API facilities.

The Prominent Key Players Operating in the Active Pharmaceutical Ingredient (API) Market Include:

  • Novartis AG (Switzerland)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • Abbott (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Bausch Health Companies Inc. (Canada)
  • UCB S.A. (Belgium)
  • Sunovion Pharmaceuticals Inc. (U.S.)
  • Jazz Pharmaceuticals, Inc. (U.K.)
  • AstraZeneca (U.K.)
  • GSK plc (U.K.)
  • H. Lundbeck A/S (Denmark)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Sumitomo Dainippon Pharma Co., Ltd. (Japan)
  • Cadila Pharmaceuticals (India)

Above are the key players covered in the report, to know about more and exhaustive list of active pharmaceutical ingredient market companies contact, https://www.databridgemarketresearch.com/contact

Research Methodology: Global Active Pharmaceutical Ingredient (API) Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.

 


Client Testimonials